PYHIN1 Antikörper (AA 1-245)
-
- Target Alle PYHIN1 Antikörper anzeigen
- PYHIN1 (Pyrin and HIN Domain Family, Member 1 (PYHIN1))
-
Bindungsspezifität
- AA 1-245
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser PYHIN1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Kreuzreaktivität
- Human, Maus
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Pyrin and HIN domain-containing protein 1 protein (1-245AA)
- Isotyp
- IgG
- Top Product
- Discover our top product PYHIN1 Primärantikörper
-
-
- Applikationshinweise
- Recommended dilution: WB:1:1000-1:5000,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- PYHIN1 (Pyrin and HIN Domain Family, Member 1 (PYHIN1))
- Andere Bezeichnung
- PYHIN1 (PYHIN1 Produkte)
- Synonyme
- IFIX antikoerper, RP11-520H16.1 antikoerper, 4930422C14 antikoerper, AI447904 antikoerper, Ifi209 antikoerper, Ifix antikoerper, pyrin and HIN domain family member 1 antikoerper, interferon activated gene 209 antikoerper, PYHIN1 antikoerper, Ifi209 antikoerper
- Hintergrund
-
Background: Major mediator of the tumor suppressor activity of IFN in breast cancer cells. Promotes ubiquitination and subsequent degradation of MDM2, which leads to p53/TP53 stabilization. Promotes ubiquitination and subsequent degradation of HDAC1, which in turn enhances maspin expression, and impairs invasive activity of cancer cells.
Aliases: IFIX_HUMAN antibody, Interferon-inducible protein X antibody, Pyhin1 antibody, Pyrin and HIN domain-containing protein 1 antibody
- UniProt
- Q6K0P9
-